Hypothesis: Age‑related loss of adrenal zona reticularis function and the consequent fall in DHEA stem from progressive exhaustion of adrenal progenitor cells caused by declining Wnt/β‑catenin signaling, a pathway that is advantageous early in life for adrenal growth but becomes detrimental when persisting into senescence. This represents an antagonistically pleiotropic trade‑off: genes promoting robust progenitor expansion and steroidogenesis enhance fetal and reproductive‑age adrenal capacity, yet their continued activity accelerates progenitor depletion, reducing DHEA output and removing a key anti‑inflammatory, neuroprotective steroid. The resulting inflammaging accelerates tissue damage and mortality, offering no fitness benefit and thus reflecting a non‑selected byproduct of waning selection pressure rather than an actively maintained death program.

Testable Predictions

1. Progenitor marker decline correlates with DHEA loss across the human lifespan. Quantify SF‑1⁺/CD44⁺ adrenal progenitor cells in adrenal biopsies or autopsy samples from donors aged 20‑80 and compare serum DHEA‑S levels. Expect a strong positive correlation (r > 0.6) between progenitor frequency and DHEA, independent of cortisol levels.
2. Wnt activity is high in fetal/adolescent adrenal tissue but declines with age, and its reactivation expands the progenitor pool. Measure nuclear β‑catenin and Axin2 expression (Wnt targets) in the same samples; anticipate high signaling in <20 yr donors, a gradual decline thereafter, and lowest levels in those with the greatest DHEA deficit.
3. Genetic or pharmacological augmentation of Wnt signaling in the adrenal cortex of aged mice preserves progenitor numbers, sustains DHEA production, and improves healthspan without affecting fertility. Use an inducible, adrenal‑specific β‑catenin gain‑of‑function allele (e.g., SF‑1‑CreERT2; Ctnnb1^ex3flex) activated at 12 months of life. Monitor:
   • Adrenal progenitor flow cytometry (SF‑1⁺/GATA4⁺)
   • Serum DHEA and corticosterone
   • Inflammatory markers (IL‑6, TNF‑α) and cognitive performance
   • Litter size and pup survival to ensure reproductive output unchanged. Predict: Wnt‑activated mice retain >70 % of youthful progenitor density, display DHEA levels comparable to 3‑month‑old controls, exhibit reduced inflammaging biomarkers, and show improved grip strength and memory, while litter metrics remain statistically indistinguishable from controls.
4. Blocking Wnt signaling in young adult mice accelerates progenitor loss and precipitates early DHEA decline, mimicking an aged adrenal phenotype. Apply adrenal‑specific β‑catenin knockout (SF‑1‑CreERT2; Ctnnb1^fl/fl) at 3 months. Expect a rapid drop in progenitor cells (>50 % loss by 6 months), reduced DHEA, and early onset of age‑related pathologies.

Mechanistic Rationale

Wnt/β‑catenin signaling drives adrenal stem/progenitor proliferation during fetal adrenal expansion and maintains the cortical zone throughout life. In many tissues, sustained Wnt activity leads to stem‑cell exhaustion via differentiation pressure or replicative stress. The adrenal gland, uniquely, must balance cortisol (stress) and DHEA (immunomodulatory) output; early‑life selection favors maximal steroidogenic capacity, which Wnt supports. However, the same signaling gradually depletes the progenitor reservoir that specifically fuels the zona reticularis, the DHEA‑producing layer. As progenitors dwindle, zona reticularis atrophy proceeds unchecked, cortisol production persists (or even rises due to compensatory hyperplasia), and the protective actions of DHEA wane. This creates a maladaptive endocrine milieu—high glucocorticoid/low DHEA—that promotes hippocampal atrophy, insulin resistance, and immune senescence, precisely the outcomes cited as evidence against programmed aging (see ’s discussion of flattened cortisol awakening responses and mortality risk).

Falsification

If longitudinal human data show no correlation between adrenal progenitor frequency and DHEA, or if adrenal‑specific Wnt activation in aged mice fails to rescue DHEA levels or healthspan while leaving fertility untouched, the hypothesis would be refuted. Likewise, demonstrating that Wnt manipulation alters cortisol but not DHEA, or that progenitor ablation does not affect DHEA trajectories, would undermine the proposed mechanistic link.

By framing adrenal aging as an antagonistic pleiotropic outcome of a developmental pathway, this hypothesis redirects longevity interventions from attempting to "override" a presumed death program toward modulating the balance between early‑life advantage and late‑life cost—e.g., transient, age‑timed Wnt modulation to preserve progenitor function without compromising reproductive fitness.